Tag: Celsius

  • Celsius (CELH) Stock Surges On Strong Financial Results

    Celsius (CELH) Stock Surges On Strong Financial Results

    Celsius Holdings, Inc. (NASDAQ: CELH) shares saw a remarkable 23.41% rise, trading at $31.51 as of today’s most recent check. This hike follows the announcement of financial results, revealing strategic advancements and notable revenue growth.

    Successful Financial Results

    Celsius (CELH) saw a stellar $1.36 billion in revenues for the whole year, indicating that consumers continue to want its range of functional drinks. Notably, its quarterly revenue increased 3% to $332.20 million, demonstrating how well CELH’s strategic strategies have worked to increase its market share over the long run and boost retail sales.

    Market Expansion and Consumer Engagement

    Celsius made notable strides in market penetration, contributing 30% of overall growth while category share grew by 160 basis points to 11.8%. Additionally, CELH increased the size distribution network by 37%, ensuring the presence of its products nationwide. The firm also hit a significant distribution milestone in surpassing all-commodity volume (ACV) by 98.7%.

    Alani Nutrition’s strategic acquisition

    In a strategic expansion move, Celsius on Thursday, has reached a definitive agreement to buy Alani Nutrition LLC for $1.8 billion. The net acquisition price of the deal is about $1.65 billion, which includes $150 million in tax assets. This deal, which was financed with both cash and shares, will combine two rapidly expanding energy drink brands in the US market.

    In order to establish a leading functional lifestyle platform, the combination plans to capitalize on the growing consumer demand for sugar-free energy drinks. Through its expansion into allied industries, Celsius seeks to increase its clientele and solidify its place in the market.

    Prospective Development and Market Domination

    The acquisition illustrates CELH’s continued efforts to innovate and expand its market presence. Integrating its products with Alani Nu’s product range, the company will have the capability to increase the variety and broaden its product line.

  • What is Celsius (CEL) – How does it Work?

    What is Celsius (CEL) – How does it Work?

    Celsius (CEL) is just like a financial organization, a bank in the world of cryptocurrency.

    It was launched in June 2018 and offers services such as loans and wallet-style payments, as well as prizes for depositing cryptocurrency.

    Users of the platform get paid on a monthly basis and earn interest on their investments. When utilized as a payment currency, Celsius’ native token, CEL, serves a range of internal purposes, including increasing user payouts.

    Even though banks are financial organizations, Celsius aims to get ahead of the banks in the world of financial services.

    This is done by providing greater returns on deposits. There are simple and easy conditions for providing loans to each customer. In the case of Celsius, Penalties are also removed.

    Through its CelPay feature, the platform also serves as a wallet, and it hosts its own CEL currency, which users may use to improve payout value, among other things.

    Celsius, as a for-profit corporation, takes a cut of profit margins on interest payments, but still returns 80% to consumers. Institutional entities, such as hedge funds, are also lent to by the corporation.

    Celsius’s token is based on a modified proof-of-stake algorithm, and the company’s broader security protocols were explained in a special presentation in June 2020, which is still available on its website.

    If security features like two-factor authentication are not turned on there is a danger of scamming and theft. This can be done through swapping SIMs just like with any other wallet.

    Price Movement – Celsius

    At the time of writing CEL is being traded at the rate of $4.01 with an increase of almost 4% within the last 24 hours.

    The low within this tenure was around $3.81 and the high was approximately $4.21. The coin as being on the watchlist of many traders makes it rank all the way up to number 97th. This is according to the latest data released by coinmarketcap.

    CEL during the month of May approached its new All-time High around the price of $9.25. The trading volume today on the other hand has increased by almost 180.33%.

    Price Prediction – Celsius (CEL)

    CEL has been one of the slow gainers in the market. The price is still way low as compared to the all-time high.  According to wallet investor, the price of CEL is to reach a value of $2.287in a year. For five year plan, wallet investors think that the price is to reach a value of $1.3. This means that CEL is considered a bad investment.

  • Early Morning Vibes: The 4 Best Stocks To Buy Now

    Trading on December 31 at the American stock markets ended in the green zone. The S&P 500 index climbed 0.64% to 3756 points, the Dow Jones rose 0.65%, the NASDAQ added 0.14%. S&P 500 and Dow Jones were able to hit new all-time highs thanks to positive statistics on weekly jobless claims. The growth of the indices for the whole of 2020 was 16% and 7%, respectively, while the growth of the high-tech NASDAQ over the past year was 44%.

    Company news

    Enphase Energy (ENPH: + 1.5%) will be listed in the S&P 500 starting January 7.

    Celsius Holdings (CELH: + 13.3%) will be listed in the S&P SmallCap 600 starting January 7.

    Elf Beauty (ELF: + 7.4%) will be listed on the S&P SmallCap 600 starting January 7.

    Today, global stock markets are showing positive dynamics on the first trading day of 2021. The news background remains calm, but market participants continue to bet on the recovery of the global economy this year thanks to effective vaccines and a fast vaccination process.

    However, while the vaccination campaign in the States is not so successful: as of January 2, only 4.2 million Americans received the first (of two) dose of the vaccine, although it was previously planned to reach the goal of 20 million. The head of the Operation Warp Speed organization suggested increasing the vaccination rate by halving Moderna’s vaccine dose for certain populations, negotiations are underway with the FDA regulator and company representatives. It is important to note that investors do not yet appear to be concerned about the slow pace of vaccinations.

    In Europe, there is still no desire from the authorities to soften coronavirus restrictions. Stricter measures can be taken in the UK. In general, after the holidays, a global increase in diseases and an increase in the burden on the health care system can be expected, but investors are optimistic and look at this as the peak of the fight against coronavirus, after which the burden on healthcare workers will begin to decrease and state borders will open.

    In the United States, an attempt to increase direct payments to the public from $ 600 to $ 2,000 was unsuccessful. Also over the weekend, attention was drawn to the delisting of Chinese telecom companies from American exchanges, which was a consequence of Donald Trump’s decree.

    Technical analysis

    Technically, the S&P 500 is prone to an upward movement. A new historical maximum was reached the day before. Buyers continue to demonstrate relative strength. At the same time, the RSI indicator is close to the overbought zone, so there is a risk of correction. To stay in an uptrend, the S&P 500 needs to hold above the 3640 level.

    Today Top Movers

    Nio Inc (NIO)‎, a Auto Manufacturer company, soared about 2.44% ‎at $49.93 in pre-market trading Monday after providing its December, fourth quarter and full year 2020 delivery results.‎

    ‎Canaan Inc (CAN) share price increased 20.57% to $7.15 during early morning ‎trading session on Monday.‎‎

    Castor Maritime Inc (CTRM) stock ascended 6.48% at $0.19 in the pre-‎market trading today following the announcement of pricing of $18.0 million registered direct offering.‎

    ‎Sundial Growers Inc (SNDL) gained over 2.30% at $0.48 in pre-market ‎trading on Monday.‎ The company recently revealed that it has closed the acquisition of a special purpose vehicle.

    Top Upgrades & Downgrades

    Barclays turned bullish on Ally Financial Inc. (ALLY), upgrading the stock to “Overweight” and assigning a $48 price target.

    The Goldman Sachs Group Inc. (GS) has won the favor of Barclays’s equity research team. The firm upgraded the shares from Equal-Weight to Overweight and moved their price target to $362.

    Morgan Stanley (MS) received an upgrade from analysts at Barclays, who also set their one-year price target on the stock to $88. They changed their rating on MS to Overweight from Equal-Weight in a recently issued research note.

    Earlier Monday Jefferies reduced its rating on Masco Corp (NYSE: MAS) stock to Hold from Buy and assigned the price target to $61.

    Barclays analysts reduced their investment ratings, saying in research reports covered by the media that its rating for Zions Bancorporation (NASDAQ: ZION) has been changed to Equal Weight from Overweight and the new price target is set at $50.

    Analysts at Barclays downgraded Citigroup Inc (NYSE: C)’s stock to Equal Weight from Overweight on Monday.

    Latest Insider Activity

    AbbVie Inc. (ABBV) EVP, Commercial Operations Stewart Jeffrey Ryan announced the sale of shares taking place on Dec 29 at $105.00 for some 25,290 shares. The total came to more than $2.66 million.

    Walmart Inc. (WMT) 10% Owner WALTON JIM C sold on Dec 30 a total 372,175,368 shares at $144.23 on average. The insider’s sale generated proceeds of almost $229.12 million.

    The Kroger Co. (KR) Director SARGENT RONALD declared the purchase of shares taking place on Dec 30 at $31.65 for some 3,200 shares. The transaction amount was around $0.1 million.

    Clearside Biomedical Inc. (CLSD) 10% Owner WHITMORE BRADFORD T bought on Dec 24 a total 3,179,095 shares at $1.95 on average. The purchase cost the insider an estimated $99,897.

    Important Earnings

    Top US earnings releases scheduled for tomorrow include SMART Global Holdings Inc. (NASDAQ:SGH). It will announce its Nov 2020 financial results. The company is expected to report earnings of $0.7 per share from revenues of $290.93M in the three-month period.